Posted Nov. 19, 2012 at 7:23 a.m.

Premium Lock Over the cliff: Gut check time for Tranzyme, other drug investors

Published: 2012-11-19 07:23:48
Updated: 2012-11-19 07:23:48

Tranzyme shares go over the cliff ... A screenshot from Google Finance shows Tranzyme shares plummeting in value at the market open last Thursday. Image 1 of 2 · Next Image…

A clinical trial failure triggers an 80 percent wipe-out of Tranzyme's stock value in two days. Fear of such failures is why so many investors steer clear of biotech stocks. Remember Biolex?...

Read More
Read More

WRAL TechWire any time: Twitter, Facebook

Copyright 2014 WRAL TechWire. All rights reserved.
The Skinny

The Skinny

WRAL TechWire Publisher and Editor Rick Smith dishes out tidbits from the local technology sector. Read more articles…

Please Log In to add a comment.

Best of TechWire Insider

Techwire Inside Partners

OUR INSIDERS

Dr. Mike Walden
Tech economy
Vivek Wadhwa
Commentary
Frank Vinluan
Life science
Scroll